Thrixen

About:

Diagnotics, IVD, Point of Care,

Top Investors: 22Health Ventures, John Ballantyne

Description:

Thrixen is a biotech/Medtech company that aims to revolutionise the diagnostic technology for the detection of biomarkers at the chemistry level to unlock the next generation of diagnostic and health care monitoring tools that are simple and accessible at the point of care/need.

Total Funding Amount:

$7M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2021-01-01

Contact Email:

info(AT)thrixen.com

Founders:

Hadley Sikes (Prof), Huan (Emma) Jia, Megan McBee (PhD), Patthara Kongsuphol (P.hd), Peter Preiser (Prof), Shavit Clein

Number of Employees:

1-10

Last Funding Date:

2024-04-29

IPO Status:

Private

Industries: